Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives

Volume: 56, Issue: 7, Pages: 4799 - 4811
Published: Nov 5, 2018
Abstract
Parkinson's disease is a neurodegenerative disorder accompanied by depletion of dopamine and loss of dopaminergic neurons in the brain that is believed to be responsible for the motor and non-motor symptoms in this disease. The main drug prescribed for Parkinsonian patients is L-dopa, which can be converted to dopamine by passing through the blood-brain barrier. Although L-dopa is able to improve motor function and improve the quality of life in...
Paper Details
Title
Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
Published Date
Nov 5, 2018
Volume
56
Issue
7
Pages
4799 - 4811
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.